[U.S.] December 2012 <CAFC> Santarus v. Par Pharmaceutical

日本語原文 / Japanese original

Article information

Article type: Case note

Category: United States

Topics: Support requirement

First published on this website: 2026-11-01

Display and classification checked: November 2, 2026

Originally published on Ameblo: 2024-09-14 (Japan time). Full English translation.

https://ameblo.jp/hideki-takaishi/entry-12867551677.html

[U.S.] December 2012 <CAFC> 694 F.3d 1344, Santarus v. Par Pharmaceutical

The negative expression “the gastric medication does not contain sucralfate” satisfied the written-description requirement.

The reason was explained in the specification.

⇒ The specification stated that using sucralfate in a gastric medication could cause complications damaging the gastric mucosa.

https://kilpatricktownsend.jp/%E3%82%AF%E3%83%AC%E3%83%BC%E3%83%A0%E4%B8%AD%E3%81%AE%E5%90%A6%E5%AE%9A%E7%9A%84%E9%99%90%E5%AE%9A/

Consultation guide by purpose

Update history

The first-published date remains unchanged. Display maintenance, classification changes, related-article updates, and text corrections are recorded separately.

November 1, 2026: First published on this website.

November 2, 2026: Added article information, classification, topics, language navigation, related articles where the same case was confirmed, consultation guidance, and SEO. The original text and first-published date were preserved.